Renate Krüger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Renate Krüger has a total of 216 co-authors. Here are the top co-authors by number of shared publications:
- Cornelia Feiterna-Sperling
Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
7 shared publications Horst von Bernuth
2 Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany
7 shared publicationsVolker Wahn
2 Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany
6 shared publicationsBirgit Lala
Department of Pediatric Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
4 shared publications- Horst von Bernuth
Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
4 shared publications Cornelia Feiterna-Sperling
Department of Pediatric Respiratory Medicine, Immunology, and Intensive Care Medicine, Charité—Universitätsmedizin Berlin , Berlin
3 shared publications
Latest Publications
- 10 September 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Panton–Valentine Leucocidin-positive Staphylococcus aureus Skin Infection Mimicking Mpox in a Pediatric Returning Traveler
A 4-year-old boy developed a fever followed by painful, polymorphic skin lesions after travel to Cameroon, raising suspicion for mpox. Viral testing was negative; wound culture grew Panton–Valentine leucocidin-positive Staphylococcus aureus with additional, potentially synergistic virulence genes. This case demonstrates that the differential diagnosis of skin lesions following travel should include this increasingly recognized pathogen, prompting appropriate Panton–Valentine leucocidin testing.
- 10 September 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Panton–Valentine Leucocidin-positive Staphylococcus aureus Skin Infection Mimicking Mpox in a Pediatric Returning Traveler
A 4-year-old boy developed a fever followed by painful, polymorphic skin lesions after travel to Cameroon, raising suspicion for mpox. Viral testing was negative; wound culture grew Panton–Valentine leucocidin-positive Staphylococcus aureus with additional, potentially synergistic virulence genes. This case demonstrates that the differential diagnosis of skin lesions following travel should include this increasingly recognized pathogen, prompting appropriate Panton–Valentine leucocidin testing.
- 28 April 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (4) , 589-591
A Case of Delayed Detection of Vertical Transmission of HIV-1 Due to Maternal Therapy With Long-Acting Injectable Cabotegravir Plus Rilpivirine
We report on a 4-month-old infant with delayed human immunodeficiency virus type 1 (HIV-1) diagnosis after maternal antiretroviral therapy with long-acting injectable cabotegravir plus rilpivirine (LA-CAB/RPV) in the third trimester. Prolonged viral suppression in HIV-infected infants exposed to maternal LA-CAB/RPV may necessitate molecular testing beyond 3 months of age to exclude infection.
- 28 April 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (4) , 589-591
A Case of Delayed Detection of Vertical Transmission of HIV-1 Due to Maternal Therapy With Long-Acting Injectable Cabotegravir Plus Rilpivirine
We report on a 4-month-old infant with delayed human immunodeficiency virus type 1 (HIV-1) diagnosis after maternal antiretroviral therapy with long-acting injectable cabotegravir plus rilpivirine (LA-CAB/RPV) in the third trimester. Prolonged viral suppression in HIV-infected infants exposed to maternal LA-CAB/RPV may necessitate molecular testing beyond 3 months of age to exclude infection.
- Open Access
- 4 October 2025
- Published by Springer Nature in Infection
- Vol. 54 (1) , 253-261
Tuberculosis outbreak in a German daycare center
Purpose: Young children who are exposed to people with infectious tuberculosis (TB) have an increased risk of developing TB disease following infection. The risk of infection and disease progression can be minimized by prompt identification of TB-exposed individuals and initiation of prophylactic or preventive treatment. Methods: We report on a TB outbreak in a daycare center in Berlin, Germany following a delayed diagnosis of cavitary pulmonary TB in a childhood educator. We describe contact investigation, diagnostic, prophylactic, preventive and therapeutic measures in 62 TB-exposed children (median age 3.9 years), including 30 with prolonged TB exposure. Results: The initial examination took place 5–16 days after the index patient was diagnosed with TB. Ten of the 30 children with intensive contact became infected, six (median age 2.7 years) developed pulmonary TB. Three of these children had a concurrent influenza infection, which may have contributed to disease progression. No child without prolonged exposure to the index patient developed disease. Conclusion: Early diagnosis of TB in adult patients, especially those with persistent cough, is crucial to prevent TB in vulnerable infants. Close collaboration between public health departments and specialized facilities is essential for the effective control of TB outbreaks.
- 4 October 2025
- Published by Springer Nature in Infection
- Vol. 54 (1) , 253-261
Open AccessTuberculosis outbreak in a German daycare center
Purpose: Young children who are exposed to people with infectious tuberculosis (TB) have an increased risk of developing TB disease following infection. The risk of infection and disease progression can be minimized by prompt identification of TB-exposed individuals and initiation of prophylactic or preventive treatment. Methods: We report on a TB outbreak in a daycare center in Berlin, Germany following a delayed diagnosis of cavitary pulmonary TB in a childhood educator. We describe contact investigation, diagnostic, prophylactic, preventive and therapeutic measures in 62 TB-exposed children (median age 3.9 years), including 30 with prolonged TB exposure. Results: The initial examination took place 5–16 days after the index patient was diagnosed with TB. Ten of the 30 children with intensive contact became infected, six (median age 2.7 years) developed pulmonary TB. Three of these children had a concurrent influenza infection, which may have contributed to disease progression. No child without prolonged exposure to the index patient developed disease. Conclusion: Early diagnosis of TB in adult patients, especially those with persistent cough, is crucial to prevent TB in vulnerable infants. Close collaboration between public health departments and specialized facilities is essential for the effective control of TB outbreaks.
- Open Access
- 12 June 2024
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 12, 1386959
Monogenic Inborn Errors of Immunity with impaired IgG response to polysaccharide antigens but normal IgG levels and normal IgG response to protein antigens
In patients with severe and recurrent infections, minimal diagnostic workup to test for Inborn Errors of Immunity (IEI) includes a full blood count, IgG, IgA and IgM. Vaccine antibodies against tetanus toxoid are also frequently measured, whereas testing for anti-polysaccharide IgG antibodies and IgG subclasses is not routinely performed by primary care physicians. This basic approach may cause a significant delay in diagnosing monogenic IEI that can present with an impaired IgG response to polysaccharide antigens with or without IgG subclass deficiency at an early stage. Our article reviews genetically defined IEI, that may initially present with an impaired IgG response to polysaccharide antigens, but normal or only slightly decreased IgG levels and normal responses to protein or conjugate vaccine antigens. We summarize clinical, genetic, and immunological findings characteristic for these IEI. This review may help clinicians to identify patients that require extended immunologic and genetic evaluations despite unremarkable basic immunologic findings. We recommend the inclusion of anti-polysaccharide IgG antibodies as part of the initial routine work-up for possible IEI.
- 12 June 2024
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 12, 1386959
Open AccessMonogenic Inborn Errors of Immunity with impaired IgG response to polysaccharide antigens but normal IgG levels and normal IgG response to protein antigens
In patients with severe and recurrent infections, minimal diagnostic workup to test for Inborn Errors of Immunity (IEI) includes a full blood count, IgG, IgA and IgM. Vaccine antibodies against tetanus toxoid are also frequently measured, whereas testing for anti-polysaccharide IgG antibodies and IgG subclasses is not routinely performed by primary care physicians. This basic approach may cause a significant delay in diagnosing monogenic IEI that can present with an impaired IgG response to polysaccharide antigens with or without IgG subclass deficiency at an early stage. Our article reviews genetically defined IEI, that may initially present with an impaired IgG response to polysaccharide antigens, but normal or only slightly decreased IgG levels and normal responses to protein or conjugate vaccine antigens. We summarize clinical, genetic, and immunological findings characteristic for these IEI. This review may help clinicians to identify patients that require extended immunologic and genetic evaluations despite unremarkable basic immunologic findings. We recommend the inclusion of anti-polysaccharide IgG antibodies as part of the initial routine work-up for possible IEI.
- Open Access
- 28 July 2022
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (9) , 3563-3564
Correction to: Pilot study to identify missed opportunities for prevention of childhood tuberculosis
- 28 July 2022
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (9) , 3563-3564
Open AccessCorrection to: Pilot study to identify missed opportunities for prevention of childhood tuberculosis
- Open Access
- 30 June 2022
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (9) , 3299-3307
Pilot study to identify missed opportunities for prevention of childhood tuberculosis
Tuberculosis (TB) in exposed children can be prevented with timely contact tracing and preventive treatment. This study aimed to identify potential barriers and delays in the prevention of childhood TB in a low-incidence country by assessing the management of children subsequently diagnosed with TB. A pilot retrospective cohort study included children (< 15 years) treated for TB between 2009 and 2016 at a tertiary care hospital in Berlin, Germany. Clinical data on cases and source cases, information on time points of the diagnostic work up, and preventive measures were collected and analyzed. Forty-eight children (median age 3 years [range 0.25–14]) were included; 36 had been identified through contact tracing, the majority (26; 72.2%) being < 5 years. TB source cases were mostly family members, often with advanced disease. Thirty children (83.3%) did not receive prophylactic or preventive treatment, as TB was already prevalent when first presented. Three cases developed TB despite preventive or prophylactic treatment; in three cases (all < 5 years), recommendations had not been followed. Once TB was diagnosed in source cases, referral, assessment, TB diagnosis, and treatment were initiated in most children in a timely manner with a median duration of 18 days (interquartile range 6–60, range 0–252) between diagnosis of source case and child contact (information available for 35/36; 97.2%). In some cases, notable delays in follow-up occurred.Conclusion: Prompt diagnosis of adult source cases appears to be the most important challenge for childhood TB prevention. However, improvement is also needed in the management of exposed children. What is Known:• Following infection with Mycobacterium tuberculosis, young children have a high risk of progression to active and severe forms of tuberculosis (TB).• The risk of infection and disease progression can be minimized by prompt identification of TB-exposed individuals and initiation of prophylactic or preventive treatment. What is New:• We could show that there are avoidable time lags in diagnosis in a relevant proportion of children with known TB exposure.• Delayed diagnosis of adult source cases, losses in follow-up examinations, and delay in referral to a specialized TB clinic of TB-exposed children, especially among foreign-born children, appear to be the main issue in this German pediatric study cohort.
- 30 June 2022
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (9) , 3299-3307
Open AccessPilot study to identify missed opportunities for prevention of childhood tuberculosis
Tuberculosis (TB) in exposed children can be prevented with timely contact tracing and preventive treatment. This study aimed to identify potential barriers and delays in the prevention of childhood TB in a low-incidence country by assessing the management of children subsequently diagnosed with TB. A pilot retrospective cohort study included children (< 15 years) treated for TB between 2009 and 2016 at a tertiary care hospital in Berlin, Germany. Clinical data on cases and source cases, information on time points of the diagnostic work up, and preventive measures were collected and analyzed. Forty-eight children (median age 3 years [range 0.25–14]) were included; 36 had been identified through contact tracing, the majority (26; 72.2%) being < 5 years. TB source cases were mostly family members, often with advanced disease. Thirty children (83.3%) did not receive prophylactic or preventive treatment, as TB was already prevalent when first presented. Three cases developed TB despite preventive or prophylactic treatment; in three cases (all < 5 years), recommendations had not been followed. Once TB was diagnosed in source cases, referral, assessment, TB diagnosis, and treatment were initiated in most children in a timely manner with a median duration of 18 days (interquartile range 6–60, range 0–252) between diagnosis of source case and child contact (information available for 35/36; 97.2%). In some cases, notable delays in follow-up occurred.Conclusion: Prompt diagnosis of adult source cases appears to be the most important challenge for childhood TB prevention. However, improvement is also needed in the management of exposed children. What is Known:• Following infection with Mycobacterium tuberculosis, young children have a high risk of progression to active and severe forms of tuberculosis (TB).• The risk of infection and disease progression can be minimized by prompt identification of TB-exposed individuals and initiation of prophylactic or preventive treatment. What is New:• We could show that there are avoidable time lags in diagnosis in a relevant proportion of children with known TB exposure.• Delayed diagnosis of adult source cases, losses in follow-up examinations, and delay in referral to a specialized TB clinic of TB-exposed children, especially among foreign-born children, appear to be the main issue in this German pediatric study cohort.
- Open Access
- 2 June 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 886540
Case Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders – Outcome After Hematopoietic Stem Cell Transplantation
We report two patients with DNA repair disorders (Artemis deficiency, Ataxia telangiectasia) with destructive skin granulomas, presumably triggered by live-attenuated rubella vaccinations. Both patients showed reduced naïve T cells. Rapid resolution of skin lesions was observed following hematopoietic stem cell transplantation. However, the patient with AT died due to complications of severe hepatic veno-occlusive disease 6 month after HSCT. Dried blood spots obtained after birth were available from this patient and showed absent T-cell receptor excision circles (TRECs). Therefore, newborn screening may help to prevent patients with moderate T-cell deficiency from receiving live-attenuated rubella vaccine potentially causing granulomas.
- 2 June 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 886540
Open AccessCase Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders – Outcome After Hematopoietic Stem Cell Transplantation
We report two patients with DNA repair disorders (Artemis deficiency, Ataxia telangiectasia) with destructive skin granulomas, presumably triggered by live-attenuated rubella vaccinations. Both patients showed reduced naïve T cells. Rapid resolution of skin lesions was observed following hematopoietic stem cell transplantation. However, the patient with AT died due to complications of severe hepatic veno-occlusive disease 6 month after HSCT. Dried blood spots obtained after birth were available from this patient and showed absent T-cell receptor excision circles (TRECs). Therefore, newborn screening may help to prevent patients with moderate T-cell deficiency from receiving live-attenuated rubella vaccine potentially causing granulomas.
- 3 January 2022
- Published by Georg Thieme Verlag KG in Klinische Padiatrie
- Vol. 234 (05) , 314-316
Eine seltene Ursache eines einseitigen Pleuraergusses bei einer jugendlichen Patientin
Es handelt sich um eine 14 Jahre alte Patientin, die vor 10 Jahren mit ihrer Familie aus Syrien geflohen ist und sich seit 6 Jahren in Deutschland aufhält. Die Unterbringung erfolgte in verschiedenen Flüchtlingsunterkünften. Bei der Erstuntersuchung war kein Tuberkulose-Screening bei dem Mädchen erfolgt. Seit zwei Wochen sei es zu nicht produktivem Husten, linksseitigen Thoraxschmerzen, Abgeschlagenheit und seit einer Woche zu leichtem Fieber gekommen. Ein Gewichtsverlust sei nicht aufgetreten. Die Vorstellung in unserer Klinik erfolgte bei ausbleibender Besserung unter ambulanter Amoxicillin-Therapie. Die Familien- und Eigenanamnese war unauffällig, aus der Umgebungsanamnese ergab sich kein Hinweis auf eine Tuberkulose (TB). Publication Date: 03 January 2022 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- 3 January 2022
- Published by Georg Thieme Verlag KG in Klinische Padiatrie
- Vol. 234 (05) , 314-316
Eine seltene Ursache eines einseitigen Pleuraergusses bei einer jugendlichen Patientin
Es handelt sich um eine 14 Jahre alte Patientin, die vor 10 Jahren mit ihrer Familie aus Syrien geflohen ist und sich seit 6 Jahren in Deutschland aufhält. Die Unterbringung erfolgte in verschiedenen Flüchtlingsunterkünften. Bei der Erstuntersuchung war kein Tuberkulose-Screening bei dem Mädchen erfolgt. Seit zwei Wochen sei es zu nicht produktivem Husten, linksseitigen Thoraxschmerzen, Abgeschlagenheit und seit einer Woche zu leichtem Fieber gekommen. Ein Gewichtsverlust sei nicht aufgetreten. Die Vorstellung in unserer Klinik erfolgte bei ausbleibender Besserung unter ambulanter Amoxicillin-Therapie. Die Familien- und Eigenanamnese war unauffällig, aus der Umgebungsanamnese ergab sich kein Hinweis auf eine Tuberkulose (TB). Publication Date: 03 January 2022 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 1 January 2021
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 32, 101324
Mediastinal mass in an tuberculosis-exposed 2-year old child with neurofibromatosis type 1 – TB or not TB?
- 1 January 2021
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 32, 101324
Open AccessMediastinal mass in an tuberculosis-exposed 2-year old child with neurofibromatosis type 1 – TB or not TB?
- Open Access
- 3 December 2020
- Published by American Society of Hematology in Blood
- Vol. 136 (23) , 2638-2655
Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency
Biallelic mutations in the genes encoding CD27 or its ligand CD70 underlie inborn errors of immunity (IEIs) characterized predominantly by Epstein-Barr virus (EBV)-associated immune dysregulation, such as chronic viremia, severe infectious mononucleosis, hemophagocytic lymphohistiocytosis (HLH), lymphoproliferation, and malignancy. A comprehensive understanding of the natural history, immune characteristics, and transplant outcomes has remained elusive. Here, in a multi-institutional global collaboration, we collected the clinical information of 49 patients from 29 families (CD27, n = 33; CD70, n = 16), including 24 previously unreported individuals and identified a total of 16 distinct mutations in CD27, and 8 in CD70, respectively. The majority of patients (90%) were EBV+ at diagnosis, but only ∼30% presented with infectious mononucleosis. Lymphoproliferation and lymphoma were the main clinical manifestations (70% and 43%, respectively), and 9 of the CD27-deficient patients developed HLH. Twenty-one patients (43%) developed autoinflammatory features including uveitis, arthritis, and periodic fever. Detailed immunological characterization revealed aberrant generation of memory B and T cells, including a paucity of EBV-specific T cells, and impaired effector function of CD8+ T cells, thereby providing mechanistic insight into cellular defects underpinning the clinical features of disrupted CD27/CD70 signaling. Nineteen patients underwent allogeneic hematopoietic stem cell transplantation (HSCT) prior to adulthood predominantly because of lymphoma, with 95% survival without disease recurrence. Our data highlight the marked predisposition to lymphoma of both CD27- and CD70-deficient patients. The excellent outcome after HSCT supports the timely implementation of this treatment modality particularly in patients presenting with malignant transformation to lymphoma.
- 3 December 2020
- Published by American Society of Hematology in Blood
- Vol. 136 (23) , 2638-2655
Open AccessExtended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency
Biallelic mutations in the genes encoding CD27 or its ligand CD70 underlie inborn errors of immunity (IEIs) characterized predominantly by Epstein-Barr virus (EBV)-associated immune dysregulation, such as chronic viremia, severe infectious mononucleosis, hemophagocytic lymphohistiocytosis (HLH), lymphoproliferation, and malignancy. A comprehensive understanding of the natural history, immune characteristics, and transplant outcomes has remained elusive. Here, in a multi-institutional global collaboration, we collected the clinical information of 49 patients from 29 families (CD27, n = 33; CD70, n = 16), including 24 previously unreported individuals and identified a total of 16 distinct mutations in CD27, and 8 in CD70, respectively. The majority of patients (90%) were EBV+ at diagnosis, but only ∼30% presented with infectious mononucleosis. Lymphoproliferation and lymphoma were the main clinical manifestations (70% and 43%, respectively), and 9 of the CD27-deficient patients developed HLH. Twenty-one patients (43%) developed autoinflammatory features including uveitis, arthritis, and periodic fever. Detailed immunological characterization revealed aberrant generation of memory B and T cells, including a paucity of EBV-specific T cells, and impaired effector function of CD8+ T cells, thereby providing mechanistic insight into cellular defects underpinning the clinical features of disrupted CD27/CD70 signaling. Nineteen patients underwent allogeneic hematopoietic stem cell transplantation (HSCT) prior to adulthood predominantly because of lymphoma, with 95% survival without disease recurrence. Our data highlight the marked predisposition to lymphoma of both CD27- and CD70-deficient patients. The excellent outcome after HSCT supports the timely implementation of this treatment modality particularly in patients presenting with malignant transformation to lymphoma.